Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Collagen-binding integrins are a specialized subgroup of the integrin family of cell-surface receptors, comprising four distinct alpha-beta heterodimers: alpha-1 beta-1 (VLA-1), alpha-2 beta-1 (VLA-2), alpha-10 beta-1, and alpha-11 beta-1 (Zeltz & Gullberg, 2016). These receptors are primary mediators of cell interaction with the collagenous extracellular matrix (ECM), recognizing specific triple-helical motifs such as GFOGER (Leitinger, 2011). They play fundamental roles in physiological processes including cell adhesion, migration, survival, and the regulation of ECM synthesis. In disease states, collagen-binding integrins are frequently dysregulated; for instance, alpha-1 beta-1 and alpha-2 beta-1 are involved in promoting tumor angiogenesis and metastasis, as well as driving fibrotic responses in the liver, lungs, and kidneys (Popov et al., 2011). Therapeutic targeting of these integrins, primarily through monoclonal antibodies or small molecule inhibitors like SAR113945 or BTT1023, aims to mitigate chronic inflammation and fibrotic progression by disrupting aberrant cell-collagen signaling pathways (McCall-Culbreath & Zutter, 2008).
Antagonism of collagen binding and inhibition of downstream signaling pathways
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Collagen-binding integrin.